Literature DB >> 21708199

NASH animal models: are we there yet?

Rohit Kohli1, Ariel E Feldstein.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21708199     DOI： 10.1016/j.jhep.2011.04.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  19 in total

Review 1.  Fatty liver disease in children--what should one do?

Authors:  Kristin S Bramlage; Vivek Bansal; Stavra A Xanthakos; Rohit Kohli
Journal:  Indian J Pediatr       Date:  2012-06-22       Impact factor: 1.967

Review 2.  Drug-induced steatohepatitis.

Authors:  Ajit Dash; Robert A Figler; Arun J Sanyal; Brian R Wamhoff
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-10-27       Impact factor: 4.481

3.  Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury.

Authors:  Sanjoy Roychowdhury; Rebecca L McCullough; Carlos Sanz-Garcia; Paramananda Saikia; Naim Alkhouri; Ammar Matloob; Katherine A Pollard; Megan R McMullen; Colleen M Croniger; Laura E Nagy
Journal:  Hepatology       Date:  2016-07-17       Impact factor: 17.425

4.  Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system.

Authors:  A Dash; R A Figler; B R Blackman; S Marukian; M S Collado; M J Lawson; S A Hoang; A J Mackey; D Manka; B K Cole; R E Feaver; A J Sanyal; B R Wamhoff
Journal:  Toxicol In Vitro       Date:  2016-12-07       Impact factor: 3.500

5.  Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.

Authors:  Hayley T Nicholls; Jason L Hornick; David E Cohen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-06       Impact factor: 4.052

6.  Bioinformatics analysis of an animal model of diet-induced nonalcoholic fatty liver disease with rapid progression.

Authors:  Wei Hong; Tingting Zhang; Junbin Yan; Jianshun Yu; Beihui He; Liyan Wu; Kannan Yao; Wei Mao; Zhiyun Chen
Journal:  Exp Biol Med (Maywood)       Date:  2021-11-13

7.  Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells.

Authors:  Davide Povero; Akiko Eguchi; Ingrid R Niesman; Nektaria Andronikou; Xavier de Mollerat du Jeu; Anny Mulya; Michael Berk; Milos Lazic; Samjana Thapaliya; Maurizio Parola; Hemal H Patel; Ariel E Feldstein
Journal:  Sci Signal       Date:  2013-10-08       Impact factor: 8.192

8.  Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis.

Authors:  Akiko Eguchi; Xavier De Mollerat Du Jeu; Casey D Johnson; Andronikou Nektaria; Ariel E Feldstein
Journal:  J Hepatol       Date:  2015-11-07       Impact factor: 25.083

9.  Characterizing disease progression of nonalcoholic steatohepatitis in Leptin-deficient rats by integrated transcriptome analysis.

Authors:  Ping Lu; Guang Yang; Lichun Jiang; Wen He; Wanwan Wu; Lingbin Qi; Shijun Shen; Junhua Rao; Peng Zhang; Zhigang Xue; Cizhong Jiang; Guoping Fan; Xianmin Zhu
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-10

10.  A post-developmental genetic screen for zebrafish models of inherited liver disease.

Authors:  Seok-Hyung Kim; Shu-Yu Wu; Jeong-In Baek; Soo Young Choi; Yanhui Su; Charles R Flynn; Joshua T Gamse; Kevin C Ess; Gary Hardiman; Joshua H Lipschutz; Naji N Abumrad; Don C Rockey
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.